The Role of CD34 + Stem Cells and Biomarkers in the Development of CAV in HTX Patients
Clinical trial NCT05485467 · COMPLETED
Trial details
- NCT number
- NCT05485467
- Sponsor
- University Medical Centre Ljubljana
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-01
- Primary completion
- 2022-08-15
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.